<DOC>
	<DOCNO>NCT01829139</DOCNO>
	<brief_summary>In patient gallbladder situ complete removal common bile duct ( CBD ) stone , definite guideline management remnant acalculous gallbladder . This study plan evaluate efficacy choleretic agent patient compare non-treatment group short ( 2 year ) long-term ( 5 10 year ) period . So , investigator want establish treatment guideline gallbladder situ without definite stone follow complete removal CBD stone . Second , protective preventive effect choleretics may define .</brief_summary>
	<brief_title>Efficacy Choleretics Acalculous Gallbladder Situ After Endoscopic Removal Biliary Stones</brief_title>
	<detailed_description />
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Cholelithiasis</mesh_term>
	<mesh_term>Cholecystolithiasis</mesh_term>
	<mesh_term>Gallstones</mesh_term>
	<mesh_term>Cholagogues Choleretics</mesh_term>
	<criteria>Complete clearance CBD stone No definite GB stone Agree study protocol &lt; 18 year age Concomitant IHD stone Combined malignancy limted life span Prior cholecystectomy state refusal agree study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Common bile duct stone</keyword>
	<keyword>Gallbladder situ</keyword>
	<keyword>Choleretics</keyword>
</DOC>